Evogene Ltd.

NASDAQ: EVGN · Real-Time Price · USD
1.34
-0.02 (-1.47%)
At close: Aug 15, 2025, 3:59 PM
1.38
2.60%
After-hours: Aug 15, 2025, 05:50 PM EDT

Evogene Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
6.76M 8.51M 7.48M 9.45M 9.19M 5.64M 5.72M 2.42M 2.08M 1.68M 1.33M 1.01M 834K 930K 970K 1.14M 1.3M
Cost of Revenue
4.6M 3.3M 3.6M 3.03M 2.34M 2.35M 1.66M 1.27M 1.07M 909K 812K 793K 659K 767K 846K 820K 806K
Gross Profit
2.17M 5.21M 3.88M 6.42M 6.85M 3.29M 4.06M 1.15M 1.01M 766K 514K 218K 175K 163K 124K 315K 492K
Operating Income
-22.25M -22.21M -25.27M -22M -23.8M -26.51M -22.66M -25.58M -25.68M -26.94M -31.85M -33.31M -32.75M -30.95M -29.44M -26.43M -24.21M
Interest Income
4.02M 2.82M 2.94M 1.22M 1.35M 1.25M 1.3M 1.06M 1.11M 848K 1.62M 1.8M 1.92M 1.94M 1.73M 1.56M 1.51M
Pretax Income
-17.17M -18.02M -25.37M -21.01M -22.81M -25.99M -22.42M -25.72M -27.68M -29.75M -34.07M -35.24M -32.42M -30.43M -31.08M -28.16M -26.08M
Net Income
-15.21M -16.48M -23.51M -19.87M -21.47M -23.88M -20.28M -22.84M -24.63M -26.64M -31.01M -32.08M -29.47M -27.79M -28.54M -25.72M -23.75M
Selling & General & Admin
10.16M 10.87M 11.11M 9.74M 10.01M 9.68M 10.24M 9.42M 8.37M 7.65M 6.83M 7.28M 7.39M 7.25M 6.95M 6.18M 5.44M
Research & Development
14.44M 16.04M 17.52M 18.15M 20.11M 20.11M 19.98M 20.81M 21.82M 23.56M 25.54M 26.25M 25.53M 23.86M 22.61M 20.57M 19.27M
Other Expenses
-186K 5K 5K 5K n/a n/a -3.5M -3.5M -3.5M -3.5M n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
24.41M 27.42M 29.14M 28.41M 30.64M 29.79M 26.73M 26.73M 26.69M 27.71M 32.37M 33.53M 32.92M 31.12M 29.56M 26.75M 24.71M
Interest Expense
3.64M 3.34M 2.81M 14K 139K 511K 1.06M 1.2M 3.11M 3.66M 3.83M 3.74M 1.6M 1.41M 3.37M 3.29M 3.37M
Selling & Marketing Expenses
475K 822K 1.21M 1.2M 1.2M 1.01M 3.75M 2.9M 1.97M 1.17M n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
29.02M 30.72M 32.75M 31.45M 32.99M 32.15M 28.38M 28M 27.76M 28.62M 33.18M 34.32M 33.58M 31.88M 30.41M 27.57M 25.51M
Income Tax Expense
9K 9K -2K -8K 12K -33K 16K 26K 43K 90K 39K 42K 7K 13K 44K 36K 34K
Shares Outstanding (Basic)
6.8M 6.8M 5.81M 5.09M 5.06M 5.06M 4.89M 4.52M 4.15M 41.23M 41.22M 41.2M 41.19M 41.18M 40.85M 40.58M 38.96M
Shares Outstanding (Diluted)
6.8M 6.8M 5.81M 5.09M 5.06M 5.06M 4.89M 4.52M 4.15M 41.23M 41.22M 41.2M 41.19M 41.18M 40.85M 40.58M 38.96M
EPS (Basic)
-2.69 -3.07 -4.43 -3.93 -4.42 -5.17 -3.94 -3.29 -1.98 -0.69 -0.8 -0.83 -0.74 -0.69 -0.75 -0.74 -0.75
EPS (Diluted)
-2.69 -3.07 -4.43 -3.93 -4.42 -5.17 -3.94 -3.29 -1.98 -0.69 -0.8 -0.83 -0.74 -0.69 -0.75 -0.74 -0.75
EBITDA
-14.4M -15.46M -19.88M -18.3M -19.93M -22.77M -18.77M -21.94M -22.03M -23.51M -28.84M -30.21M -29.57M -27.88M -27.88M -24.87M -22.55M
EBIT
-16.83M -17.98M -22.97M -21.41M -23.06M -25.87M -21.36M -24.51M -24.57M -26.09M -31.33M -32.61M -31.92M -30.12M -30.42M -27.58M -25.42M
Depreciation & Amortization
2.41M 2.5M 2.57M 2.61M 2.64M 2.61M 2.59M 2.57M 2.54M 2.58M 2.49M 2.39M 2.35M 2.23M 2.31M 2.48M 2.63M